Sulfadiazine

磺胺嘧啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfadiazine
Drug Alias Name碲胺嘧啶FlamazineFlammazineAgSDNSC-625324
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1941/08/26
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co LtdMitsubishi Tanabe Pharma
Inactive CompaniesEli Lilly And CompanyVita Health Products Inc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01EC02
Related LinksWikipediaDrugBankKEGG